Cognitive, Emotional, and Psychosocial Functioning of Girls Treated with Pharmacological Puberty Blockage for Idiopathic Central Precocious Puberty
Wojniusz, Slawomir; Callens, Nina; Sütterlin, Stefan; Andersson, Stein; Schepper, Jean De; Gies, Inge; Vanbesien, Jesse; Waele, Kathleen De; Aken, Sara Van; Craen, Margarita; Vögele, Claus; Cools, Martine; Haraldsen, Ira R.
Original version
10.3389/fpsyg.2016.01053Abstract
Central precocious puberty (CPP) develops due to premature activation of the
hypothalamic-pituitary-gonadal (HPG) axis, resulting in early pubertal changes and
rapid bone maturation. CPP is associated with lower adult height and increased
risk for development of psychological problems. Standard treatment of CPP is
based on postponement of pubertal development by blockade of the HPG axis with
gonadotropin releasing hormone analogs (GnRHa) leading to abolition of gonadal sex
hormones synthesis. Whereas the hormonal and auxological effects of GnRHa are
well-researched, there is a lack of knowledge whether GnRHa treatment influences
psychological functioning of treated children, despite the fact that prevention of
psychological problems is used as one of the main reasons for treatment initiation. In
the present study we seek to address this issue by exploring differences in cognitive
function, behavior, emotional reactivity, and psychosocial problems between GnRHa
treated CPP girls and age-matched controls. Fifteen girls with idiopathic CPP; median
age 10.4 years, treated with slow-release GnRHa (triptorelin acetate—Decapeptyl
SR® 11.25) and 15 age-matched controls, were assessed with a comprehensive
test battery consisting of paper and pencil tests, computerized tasks, behavioral
paradigms, heart rate variability, and questionnaires filled in by the children’s parents.
Both groups showed very similar scores with regard to cognitive performance,
behavioral and psychosocial problems. Compared to controls, treated girls displayed
significantly higher emotional reactivity (p = 0.016; Cohen’s d = 1.04) on one of
the two emotional reactivity task conditions. Unexpectedly, the CPP group showed
significantly lower resting heart rates than the controls (p = 0.004; Cohen’s d = 1.03);
lower heart rate was associated with longer treatment duration (r = −0.582,
p = 0.037). The results suggest that GnRHa treated CPP girls do not differ in their cognitive or psychosocial functioning from age matched controls. However, they
might process emotional stimuli differently. The unexpected finding of lower heart rate
that was associated with longer duration of the treatment should be further explored by
methods appropriate for assessment of cardiac health.